ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.310,86
0,05%
Dow Jones
39.838,57
0,08%
Euro vs US Dollar
1,08541
-0,06%
Bitcoin
69.857,35
-2,23%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)

  7. PharmaCyte Biotech Inc (PMCB) News

PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PMCB
DatumZeitQuelleÜberschriftSymbolFirma
21/05/202415h00Business WirePharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory DiseaseNASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202421h38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
06/02/202415h56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/12/202323h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
28/11/202323h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
24/11/202322h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202322h00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
15/11/202314h30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
09/11/202323h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
31/10/202314h15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
31/10/202314h15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
02/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
21/09/202323h04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
18/09/202312h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
15/09/202323h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
12/09/202303h56Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
07/09/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
04/08/202322h40Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
04/08/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202323h18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202322h42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
19/07/202316h28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
16/06/202323h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202322h02Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PMCB

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
FX
EURUSD
Euro vs US Dollar
TG
CBK
Commerzbank
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
DBI
MDAX
MDAX
AMEX
XLV
Health Care Select Sector
DBI
SDXP
SDAX
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
TG
TUI1
Tui
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten